You are here » Home » Companies » Company Overview » Astrazeneca Pharma India Ltd

Astrazeneca Pharma India Ltd.

BSE: 506820 Sector: Health care
NSE: ASTRAZEN ISIN Code: INE203A01020
BSE LIVE 15:40 | 25 Jul 1051.00 6.65
(0.64%)
OPEN

1049.95

HIGH

1060.00

LOW

1032.75

NSE LIVE 15:53 | 25 Jul 1049.00 3.65
(0.35%)
OPEN

1035.00

HIGH

1062.00

LOW

1021.15

OPEN 1049.95
PREVIOUS CLOSE 1044.35
VOLUME 869
52-Week high 1348.00
52-Week low 1008.90
P/E 502.87
Mkt Cap.(Rs cr) 2627.50
Buy Price 0.00
Buy Qty 0.00
Sell Price 1050.00
Sell Qty 15.00
OPEN 1049.95
CLOSE 1044.35
VOLUME 869
52-Week high 1348.00
52-Week low 1008.90
P/E 502.87
Mkt Cap.(Rs cr) 2627.50
Buy Price 0.00
Buy Qty 0.00
Sell Price 1050.00
Sell Qty 15.00

About Astrazeneca Pharma India Ltd.

Astrazeneca Pharma India Ltd

Astrazeneca Pharma India formerly known as Astra-IDL (AIL), a joint venture of Astra Zeneca, UK and Hinduja controlled IDL is a market leader in local anesthetics with xylocaine. The, UB's 100% subsidiary, UB Biotek, has tied up with the Company to market its newly-patented anti-obesity nutraceutical. The herbal product, Hydroxycitrisol, extracted from garcinia (kokum), is one of two UB techno...> More

Astrazeneca Pharma India Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   2,628
EPS - TTM () [*S] 2.09
P/E Ratio (X) [*S] 502.87
Face Value ()   2
Latest Dividend (%)   175.00
Latest Dividend Date 09 Jul 2012
Dividend Yield (%) 0.00
Book Value / Share () [*S] 62.41
P/B Ratio () [*S] 16.84
[*C] Consolidated     [*S] Standalone

Astrazeneca Pharma India Ltd - Financial Results

Particulars ( cr) Mar 2016 Mar 2015 % Chg
Net Sales 158.82 168.55 -5.77
Other Income 2.09 1.35 54.81
Total Income 160.91 169.9 -5.29
Total Expenses 155.61 127.75 21.81
Operating Profit 5.3 42.15 -87.43
Net Profit 0.56 38.13 -98.53
Equity Capital 5 5 -
> More on Astrazeneca Pharma India Ltd Financials Results

Astrazeneca Pharma India Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Vinati Organics 529.60 1.67 2732.74
Unichem Labs. 294.25 -2.98 2673.26
Suven Life Scie. 208.80 -0.17 2658.02
Astrazeneca Phar 1051.00 0.64 2627.50
Dishman Pharma. 142.90 -2.39 2306.41
Novartis India 716.05 -0.81 2288.50
J B Chem & Pharm 267.90 0.41 2271.79
> More on Astrazeneca Pharma India Ltd Peer Group

Astrazeneca Pharma India Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 75.00
Banks/FIs 0.06
FIIs 5.19
Insurance 0.00
Mutual Funds 7.09
Indian Public 10.66
Custodians 0.00
Other 1.99
> More on Astrazeneca Pharma India Ltd Share Holding Pattern

Astrazeneca Pharma India Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 0.59% 0.33% 1.26% 1.49%
1 Month -1.36% -1.78% 6.43% 6.76%
3 Month -10.41% -10.74% 9.41% 9.94%
6 Month -12.90% -13.06% 14.74% 16.13%
1 Year -10.60% -10.66% -0.06% 1.34%
3 Year 62.17% 61.91% 41.86% 46.18%

Astrazeneca Pharma India Ltd - STOCK STRENGTH

Today's Low/High 1032.75
1060.00
Week Low/High 1024.90
1068.00
Month Low/High 1024.90
1125.00
YEAR Low/High 1008.90
1348.00
All TIME Low/High 3.75
2649.00
Widgets Magazine
Widgets Magazine
Widgets Magazine

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard